This, That, The Other:

Share on FacebookTweet about this on TwitterPin on PinterestShare on StumbleUpon

Searchable News & Info From Reliable Online Sources.

  • What is the White House press pool and why is it in a row with Trump?
    The White House press pool is at the centre of a major row between President Donald Trump and TV networks. What is it? [TheTopNews] Read More.
    BBC NEWS – United States & Canada | U.S. National NewsTue, September 22, 2026
    2 hours ago
  • Drugmakers face lawsuits alleging GLP-1 medications caused sudden vision loss
    Manufacturers dispute that the drugs caused their injuries. By Mark Huffman of ConsumerAffairs September 22, 2026 Patients are suing Novo Nordisk and Eli Lilly, alleging their diabetes and weight-loss drugs caused sudden, sometimes permanent vision loss.European regulators classify the eye condition NAION as a very rare side effect of semaglutide, the ingredient in Ozempic and Wegovy.The companies dispute the allegations, and questions about causation and adequate warnings remain central to the litigation.Patients who say they suffered sudden vision loss after taking popular diabetes and weight-loss medications are pursuing lawsuits against Novo Nordisk and Eli Lilly, alleging the manufacturers failed to adequately warn them about a potentially devastating eye condition.The lawsuits concern nonarteritic anterior ischemic optic neuropathy, or NAION, which occurs when inadequate blood flow damages the optic nerve. The resulting loss of vision can be permanent.Federal cases have been consolidated in the Eastern District of Pennsylvania before U.S. District Judge Karen Spencer Marston. The litigation encompasses allegations involving Ozempic, Wegovy, Rybelsus, Saxenda, Trulicity, Mounjaro and Zepbound, according to a July 2 court order.The medications do not all contain the same active ingredient, an important distinction when evaluating evidence about potential risks.What the suits claimPlaintiffs allege failures to warn, defective design and breaches of warranties. Consolidating their cases allows common pretrial issues to be handled together; it does not establish that the drugs caused their injuries. The December 2025 transfer order created a separate proceeding for vision-loss claims, distinct from litigation over gastrointestinal injuries.In July, Marston ordered early evidence gathering and legal arguments on whether the medications can cause NAION and on issues involving warning adequacy and federal law. Her order reported more than 130 cases in the proceeding at that time.Novo Nordisk and Eli Lilly deny the allegations and dispute that the evidence establishes a causal connection, according to The Wall Street Journals September 19 report.The regulatory picture adds another dimension to the lawsuits.Regulatory issuesIn June 2025, the European Medicines Agencys safety committee concluded that NAION is a very rare side effect of semaglutide. Its review covered clinical trials, observational studies, postmarketing reports and other evidence.Several large studies suggested approximately twice the risk among adults with Type 2 diabetes taking semaglutide compared with those not taking it. In absolute terms, that translated into approximately one additional case per 10,000 people treated for one year, according to the EMA.That finding applies specifically to semaglutide and should not automatically be extended… [TheTopNews] Read More.
    CONSUMER AFFAIRS – General | Consumers & ShoppingTue, September 22, 2026
    2 hours ago
  • Earl Spencer Book Blasts Diana’s Treatment by UK Royal Family
    The decades have not lessened Earl Spencer’s anger over the House of Windsor’s treatment of the former Princess of Wales. King Charles comes in for special vitriol. [TheTopNews] Read More.
    THE NEW YORK TIMES – World News | World News & EventsTue, September 22, 2026
    2 hours ago
  • Global Oil Price Drops Below $100 a Barrel
    Investors anticipated that a damaged Saudi Arabian pipeline may be close to reopening, allowing more oil from the region to reach world markets. [TheTopNews] Read More.
    THE NEW YORK TIMES – Business | Business & CommerceTue, September 22, 2026
    2 hours ago
  • New Details Emerge on Presley Gerber’s Sudden Death at 27
    Authorities are investigating the death of Presley Gerber as a suspected overdose. A law enforcement source tells NBC News the 27-year-old son of supermodel Cindy Crawford and entrepreneur Rande Gerber, was found unresponsive at a rehab facility in Los Angeles just hours after he had checked in the night before. NBC’s Liz Kreutz reports for TODAY. [TheTopNews] Read More.
    NBC NEWS – Top Stories | U.S. National NewsTue, September 22, 2026
    2 hours ago
  • Video Shows Aftermath of ICE Agent Shooting Driver in the Back
    Protests erupted in Austin again on Monday night following the shooting of a Venezuelan delivery driver by an ICE agent. Video shows the moments officers surrounded 28-year-old Wilber Rafael Garcés Pérez after he was shot in the back. [TheTopNews] Read More.
    NBC NEWS – Top Stories | U.S. National NewsTue, September 22, 2026
    2 hours ago
1 16 17 18 19 20 85

The Searchable USWebDaily.com and TheTopNews NewsBank Helps You Be Better Informed, Faster! Spread The Word.

Click or Tap to Go to McStreamy News, Info and Entertainment
Scroll Up